MIRA INFORM REPORT

 

 

Report No. :

345028.2

Report Date :

02.11.2015

 

IDENTIFICATION DETAILS

 

Name :

BHARAT SERUMS AND VACCINES LIMITED

 

 

Formerly Known As :

GAUTAM LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

17th Floor, Hoechst House, Nariman Point, Mumbai – 400021, Maharashtra

Tel. No.:

91-22-66560900 / 66560980

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

29.04.1971

 

 

Com. Reg. No.:

11-015134

 

 

Capital Investment / Paid-up Capital :

Rs.100.483 Million

 

 

CIN No.:

[Company Identification No.]

U24230MH1971PLC015134

 

 

IEC No.:

0394068467

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMB01505A

 

 

PAN No.:

[Permanent Account No.]

AAACB2431M

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged in the manufacturing, marketing and selling of vaccines.

 

 

No. of Employees :

1500 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (51)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Bharat Serums and Vaccines Limited (BSVL), was promoted by late Dr. Vinod Draftary in April 1971 and is currently managed by Mr. Bharat Daftary and Dr. Gautam Daftary. BSVL is a biotechnology based pharmaceutical company engaged in research and manufacture of life saving drugs.

 

The rating reflects company’s healthy operational risk profile marked by well-diversified product portfolio, established distribution network and decent financial base of the company.

 

The rating further derives strength rich experience of the promoters in the pharmaceutical industry and continued financial support from the promoter. The company has a 50:50 joint venture company with Cadila Healthcare Limited (Zydus Cadila) to produce Novel Drug Delivery System(“NDDS”), for anti-cancer product, developed by BSVL, for the global markets.

 

Trade relations are reported as fair. Business is active. Payment are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long term bank facilities = A

Rating Explanation

Adequate degree of safety and low credit risk.

Date

March 24, 2015

 

Rating Agency Name

CARE

Rating

Short term bank facilities = A1

Rating Explanation

Very strong degree of safety and carry lowest credit risk.

Date

March 24, 2015

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

INFORMATION PARTED BY

 

Name :

Mr. Alexander Mascarenus

Designation :

Finance Executive

Contact No.:

91-22-45043456

Date:

12.10.2015

 

 

LOCATIONS

 

Registered Office :

17th Floor, Hoechst House, Nariman Point, Mumbai – 400021, Maharashtra, India

Tel. No.:

91-22-66560900/ 66560980

Fax No.:

91-22-66560901/ 66560903

E-Mail :

aniket.hirpara@bharatserums.com

shipa.likhite@bharatserums.com

nilesh.pingale@bharatserums.com

sharmas@orbimed.com

corporate@bharatserums.com

Website :

www.bharatserums.com

Area:

8000 Sq. Ft.

Location:

Owned

Locality:

Commercial

 

 

Corporate Office :

Airoli Office 3rd Floor, Liberty Tower, Plot No - K-10, Behind Reliable Plaza, Kalwa Industrial Estate, Airoli, Navi Mumbai – 400708, Maharashtra, India

Tel. No.:

91-22-61383456

Fax No.:

91-22-61383400

E-Mail :

corporate@bharatserums.com

export@bharatserums.com

 

 

Factory 1 :

Thane Plant

Plot No. A-371-372, Road 27, Wagle Industrial Estate, Thane – 400604,
Maharashtra, India

Tel. No.:

91-22-25822181

Fax No.:

91-22-25823640

E-Mail :

factory@bharatserums.com 

 

 

Factory 2 :

Ambernath Plant

Plot No. K-27, Anand Nagar, Additional M.I.D.C., Ambernath (East), Maharashtra, India

Tel. No.:

91-251-2621645

Fax No.:

91-251-2621089

E-Mail :

ambernath@bharatserums.com

 

 

Distribution Department :

Bhiwandi, Thane, Maharashtra, India

 

 

Khoni Animal Farm :

At Post Khoni, Ambernath M.I.D.C. Road, Khoni-Taloja Link Road, Kalyan, Thane – 421308, Maharashtra, India

Tel. No.:

91-251-2395107

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Bharat Vinod Daftary

Designation :

Managing director

Address :

114, Sneh Sadan, Churchgate, Reclamation, Mumbai – 400020, Maharashtra, India

Date of Birth/Age :

12.01.1956

Qualification :

Graduate

Date of Appointment :

01.10.2014

PAN No.:

ABPPD0877D

DIN No.:

00011518

 

 

Name :

Dr. Gautam Vinod Daftary

Designation :

Managing director

Address :

114, Sneh Sadan, Churchgate, Reclamation, Mumbai – 400020, Maharashtra, India

Date of Birth/Age :

03.10.1959

Qualification :

Doctor

Date of Appointment :

01.10.2014

PAN No.:

ABPPD0878N

DIN No.:

00009326

 

 

Name :

Mr. Siddharth Bharat Daftary

Designation :

Whole-time director

Address :

114, Sneh Sadan, Churchgate, Reclamation, Mumbai – 400020, Maharashtra, India

Date of Birth/Age :

28.12.1983

Qualification :

MSC

Date of Appointment :

01.10.2014

PAN No.:

AFKPD1429F

DIN No.:

02897197

 

 

Name :

Mr. Suketu Viren Shah

Designation :

Director

Address :

A/52, Darshan Apartments, Mt. Pleasant Road, Malabar Hill, Mumbai – 400006, Maharashtra, India

Date of Birth/Age :

04.12.1954

Qualification :

MBA from Harvard Business School

Date of Appointment :

01.10.2014

DIN No.:

00033407

 

 

Name :

Mr. Nitin Jagannath Deshmukh

Designation :

Director

Address :

Flat No. 201, Ekta Heritage, 15 Road, Khar (West), Mumbai – 400052, Maharashtra, India

Date of Birth/Age :

07.11.1962

Qualification :

MBA, MPT (UDCT)

Date of Appointment :

25.09.2009

DIN No.:

00060743

 

 

Name :

Mr. Ajeet Singh Karan

Designation :

Director

Address :

House No.36, Sector – 37, Arunvihar, Noida – 201303, Uttar Pradesh, India

Date of Birth/Age :

09.12.1965

Qualification :

IIM (Ahmedabad)

Date of Appointment :

01.10.2014

DIN No.:

00183622

 

 

Name :

Mr. Sunny Sharma

Designation :

Director

Address :

10, West End Ave Apartment, 11 H, New York - 10023

Date of Birth/Age :

31.08.1974

Qualification :

M.B.B.S. MBA from IIM, Bangalore

Date of Appointment :

16.09.2010

DIN No.:

02267273

 

 

Name :

Mrs. Kavita Vinod Khanna

Designation :

Director

Address :

13/C, ILL Plaza, Little Gibs Road, Mumbai – 400006, Maharashtra, India 

Date of Birth/Age :

31.08.1961

Date of Appointment :

30.08.2013

DIN No.:

00100979

 

 

Name :

Mr. Manu Prafull Daftary

Designation :

Director

Address :

8, Waybridge Lane, Wayland MA Wayland MA   01778

Date of Birth/Age :

21.06.1957

Qualification :

B.A. (Eco), BS, MBA (California), CFA

Date of Appointment :

01.10.2014

DIN No.:

06425237

 

 

Name :

Mr. Girish Bakre

Designation :

Executive Director

Address :

82, Sarnath, 59-B, B. Desai Road, Mumbai – 400026, Maharashtra, India

Date of Birth/Age :

06.09.1960

Date of Appointment :

01.09.2013

DIN No.:

00010760

 

 

Name :

Mr. Milind Vaidya

Designation :

Executive Director

Address :

4, Rajashree, Behind Shazy Building, off. Juhu Versova Link Road, Andheri (West), Mumbai – 400058, Maharashtra, India

Date of Birth/Age :

15.06.1958

Date of Appointment :

01.03.2014

DIN No.:

02298685

 

 

Name :

Mr. Nafeesa Adil Moloobhoy

Designation :

Additional Director

Address :

Flat No. 5, 3rd Floor, Grosvenor House, Peddar Road, Mumbai - 400026, Maharashtra, India

Date of Appointment :

08.10.2015

DIN No.:

01052240

 

 

 


 

KEY EXECUTIVES

 

Name :

Mr. Samir Vinodray Raval

Designation :

Secretary

Address :

B-308, Progressive Celebrity, Plot 71, Sector 15, CBD Belapur, Navi Mumbai - 400614, Maharashtra, India

Date of Appointment :

16.06.2015

PAN No.:

ADUPR1896C

 

 

Name :

Mr. Anil Madhusudan Damle

Designation :

Chief Financial Officer

Address :

B-108, Tulip, Maitri Complex, Pokharan Road No. 2, Majiwade Naka, Thane - 400601, Maharashtra, India

Date of Appointment :

01.05.2014

PAN No.:

ADFPD4224M

 

 

Name :

Mr. Alexander Mascarenus

Designation :

Finance Executive

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2014

 

Names of Equity Shareholders

 

No. of Shares

Vinod G. Daftary

2073954

Gaurang S Daftary

106500

Ameet S Daftary

106500

Gautam V. Daftary

1839820

Bharat V. Daftary (HUF)

776990

Gautam V. Daftary (HUF)

776990

Vinod Daftary (HUF)

750

Akshay G. Daftary Jointly with Aarti G. Daftary

750

Siddharth B. Daftary Jointly with Bhavna Daftary

750

Ansuya V. Daftary Jointly with Vinod G. Daftary

750

Nayantara H. Kothari Jointly with Sarala G. Kothari

135750

Bharat V. Daftary

1839820

Aksipro Diagnostic Private Limited, India

900000

Bharat V. Daftary Jointly with Bhavna Daftary

1906200

Gautam V. Daftary Jointly with Aarti Daftary

1906200

Aarti Daftary Jointly with Gautam Daftary

1012500

Bhavna Daftary Jointly with Bharat Daftary

1012500

Agcetech Pharmaceuticals LLP, India

155562

Czaee Shah

71000

Gauri Pohoomul

71000

Kavita Khanna

88120

Kotak Mahindra Trusteeship Services Limited - A/c Kotak India Growth Fund II, India *

1201801

Kotak India Private Equity Fund, Mauritius **

407727

Kotak Investment Advisors Limited, India

29151

Raj N. Parekh

300

Caduceus Asia Mauritius Limited, Mauritius

699358

Total

17120743

 

*The total equity shareholding of Kotak Mahindra Trusteeship Services Limited includes, Sixty One (61) Equity shares with Different Voting Rights.

 

**The total equity shareholding of Kotak India Private Equity Fund includes, Thirty Nine (39) Equity shares with Differential Voting Rights.

 

Names of Convertible Redeemable Preference Shareholders

 

No. of Shares

Kotak Mahindra Trusteeship Services Limited – A/c Kotak India Growth Fund II, India

892305

Kotak Investment Advisors Limited, India

26938

Total

919243

 

 

Names of Compulsorily Convertible Cumulative Preference Shareholder Series I

 

No. of Shares

Kotak India Private Equity Fund

714119

Total

714119

 

 

Names of Compulsorily Convertible Cumulative Preference Shareholder Series II

 

No. of Shares

Caduceus Asia Mauritius Limited, Mauritius

1342444

Total

1342444

 

As on 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

6.46

Bodies corporate

6.34

Directors or relatives of Directors

76.80

Other top fifty shareholders

3.38

Venture Capital

7.02

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in the manufacturing, marketing and selling of vaccines.

 

 

Products :

Item Code No. (ITC Code)

Product Description

30021099

Monoclonal Anti-Rho(D) Immuneglobulin

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

 

Products :

Finished Goods

Countries :

  • Russia
  • Thailand
  • Sri Lanka
  • African Countries

 

 

Imports :

 

Products :

Raw Material

Countries :

  • Singapore
  • South Korea

 

 

Terms :

 

Selling :

Cash, L/C and Credit

 

 

Purchasing :

Cash, L/C and Credit

 

PRODUCTION STATUS = NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Experience :

Not Divulged

Maximum Limit Dealt :

Not Divulged

 

 

No. of Employees :

1500 (Approximately)

 

 

Bankers :

Banker Name

IDBI Bank Limited

Branch Address

224 A, 2nd Floor, Mittal Court, Nariman Point, Mumbai – 400021, Maharashtra, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

  • Bank of Baroda, Backbay Reclamation Branch, Ram Mahal, Backbay Reclamation, Mumbai – 400020, Maharashtra, India
  • RBL Bank Limited, Shahupuri, Kolhapur – 416001, Maharashtra, India
  • Export-Import Bank of India, Centre One Building, 21 Floor, World Trade Centre , Cuffe Parade, Mumbai - 400005, Maharashtra, India
  • Cororation Bank, Overseas Branch, 1st, Floor, Earnest House, Nariman Point - 400021, Maharashtra, India

 

 

Facilities :

SECURED LOANS

31.03.2015

(Rs. in Million)

31.03.2014

(Rs. in Million)

LONG TERM BORROWINGS

 

 

Indian Rupee loan from banks

382.999

478.942

Foreign Currency loan from banks

61.375

29.736

Vehicle loan

1.602

3.183

Hire purchase loan from supplier

0.055

0.758

Loan from Department of Biotechnology

56.648

67.224

Finance lease obligations

74.162

56.689

SHORT TERM BORROWINGS

 

 

Cash credit from banks

309.579

477.222

Buyers credit from banks

63.017

210.079

Packing credit foreign currency

57.504

42.900

Foreign bill discounting

0.000

23.114

Working capital demand loan

250.000

0.000

Total

1256.941

1389.847

 

Auditors :

 

Name :

BSR and Associates

Chartered Accountants

Address :

Lodha Excelus, 1st Floor, Apollo Mills Compound, N. M. Joshi Marg, Mumbai 400011, Maharashtra, India

PAN No.:

AADFB6889R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiary company :

  • BSV Bioscience Inc, United States
  • BSV Bioscience Gmbh, Germany

 

 

Enterprises which are owned, or have significant influence of or are partners

with Key management personnel and their relatives :

  • Kasiak Research Private Limited Cn, India
  • Evergreen Family Business Advisors, India
  • Siro Clinpharm Private Limited, India

 

 

Other Related Parties :

  • Oxygen Hospital Care
  • Advy Chemicals

 

 

CAPITAL STRUCTURE

 

As on 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20987800

Equity Shares

Rs.5/-each

Rs.104.939 Million

200

Equity Shares with differenct voting rights

Rs.5/-each

Rs.0.001 Million

920000

0.01% Convertible redeemable preference shares (CRPS)

Rs.5/-each

Rs.4.600 Million

742000

0.01% Convertible cumulative preference shares (CCPS-I)

Rs.5/-each

Rs.3.710 Million

1350000

0.01% Convertible cumulative preference shares (CCPS-II)

Rs.5/-each

Rs.6.750 Million

 

Total

 

Rs.120.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

17120643

Equity Shares

Rs.5/-each

Rs.85.603 Million

100

Equity Shares with differenct voting rights

Rs.5/-each

Rs.0.001 Million

919243

0.01% Convertible redeemable preference shares (CRPS)

Rs.5/-each

Rs.4.596 Million

714119

0.01% Convertible cumulative preference shares series – I (of the above 0.175 Million shares have been issued as bonus shares by utilizing securities premium account) (CCPS-I)

Rs.5/-each

Rs.3.571 Million

1342444

0.01% Convertible cumulative preference shares series – II (CCPS-II)

Rs.5/-each

Rs.6.712 Million

 

Total

 

Rs.100.483 Million

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2015

31.03.2014

31.03.2013

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

100.483

100.483

100.483

(b) Reserves & Surplus

2441.065

2205.471

2032.373

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2541.548

2305.954

2132.856

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

645.040

718.371

649.608

(b) Deferred tax liabilities (Net)

131.744

30.121

0.000

(c) Other long term liabilities

159.364

206.456

176.207

(d) long-term provisions

45.671

28.079

27.299

Total Non-current Liabilities (3)

981.819

983.027

853.114

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

680.100

838.315

660.956

(b) Trade payables

319.743

335.531

311.643

(c) Other current liabilities

504.567

549.785

335.310

(d) Short-term provisions

130.934

103.366

142.591

Total Current Liabilities (4)

1635.344

1826.997

1450.500

 

 

 

 

TOTAL

5158.711

5115.978

4436.470

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

943.141

889.962

824.894

(ii) Intangible Assets

596.655

369.794

379.668

(iii) Capital work-in-progress

298.741

281.445

226.006

(iv) Intangible assets under development

441.356

780.817

757.395

(b) Non-current Investments

93.939

475.739

408.239

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

563.121

408.443

288.074

(e) Other Non-current assets

20.749

4.175

17.733

Total Non-Current Assets

2957.702

3210.375

2902.009

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

888.502

766.325

536.446

(c) Trade receivables

862.264

622.591

712.303

(d) Cash and cash equivalents

66.821

123.909

27.855

(e) Short-term loans and advances

290.581

246.470

222.256

(f) Other current assets

92.841

146.308

35.601

Total Current Assets

2201.009

1905.603

1534.461

 

 

 

 

TOTAL

5158.711

5115.978

4436.470

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

Income

4931.624

3643.958

3492.291

 

Other Income

77.046

61.486

17.786

 

TOTAL

5008.670

3705.444

3510.077

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1260.039

909.837

829.940

 

Purchases of Stock-in-Trade

438.730

387.941

256.861

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(73.307)

(87.915)

38.730

 

Employees benefits expense

802.075

614.493

564.203

 

Exceptional Items

136.844

0.000

0.000

 

Other expenses

1653.757

1352.549

1232.320

 

TOTAL

4218.138

3176.905

2922.054

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION 

790.532

528.539

588.023

 

 

 

 

 

Less

FINANCIAL EXPENSES

178.869

141.184

116.882

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

611.663

387.355

471.141

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

241.424

154.745

128.527

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

370.239

232.610

342.614

 

 

 

 

 

Less

TAX

101.386

30.121

20.041

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

268.853

202.489

322.573

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

 

 

 

 

Expected Sales (2015-16): Rs.6500.000 Million

 

The above information has been parted by Mr. Alexander Mascarenus (Finance Executive).

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

195.969

186.902

97.730

Cash generated from operations

523.809

391.190

NA

Net cash flows from (used in) operations

415.284

323.165

655.576

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

PAT / Sales

(%)

5.45

5.56

9.24

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

16.03

14.50

16.84

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

8.56

6.50

11.25

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.15

0.10

0.16

 

 

 

 

 

Debt Equity Ratio

(Total Debts/Networth)

 

0.60

0.76

0.61

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.35

1.04

1.06

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

100.483

100.483

100.483

Reserves & Surplus

2032.373

2205.471

2441.065

Net worth

2132.856

2305.954

2541.548

 

 

 

 

long-term borrowings

649.608

718.371

645.040

Short term borrowings

660.956

838.315

680.100

Current Maturities of Long Term Debt

97.730

186.902

195.969

Total borrowings

1408.294

1743.588

1521.109

Debt/Equity ratio

0.660

0.756

0.598

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

3492.291

3643.958

4931.624

 

 

4.343

35.337

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

3492.291

3643.958

4931.624

Profit

322.573

202.489

268.853

 

9.24%

5.56%

5.45%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

----------------------

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

----------------------

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

----------------------

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

----------------------

33

Market information

----------------------

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10534842

21/11/2014

150,000,000.00

RBL BANK LIMITED

SHAHUPURI,KOLHAPUR, KOLHAPUR, MAHARASHTRA - 416001, INDIA

C35922145

2

10413329

22/03/2013

200,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, 21 FLOOR, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

B71295315

3

10412851

22/03/2013 *

350,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, 21 FLOOR, WORLD TRADE CENTRE, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

B71978852

4

10331779

25/07/2012 *

350,000,000.00

EXPORT IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE COMPLEX, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

B45661824

5

10320221

20/03/2012 *

100,000,000.00

IDBI BANK LIMITED

DOSTI PINNACLE, GROUND FLOOR, ROAD NO.22, WAGLE INDUSTRIAL ESTATE, THANE WEST, MAHARASHTRA - 400604, INDIA

B36100238

6

10239209

31/07/2010

14,309,000.00

DEPARTMENT OF BIOTECHNOLOGY

6-8TH FLOOR, BLOCK NO. 2, CGO COMPLEX, LODHI ROAD, NEW DELHI, DELHI - 110003, INDIA

A94241536

7

10209223

21/10/2010 *

160,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE COMPLEX, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

A96933908

8

10181585

29/09/2009

65,000,000.00

CORORATION BANK

OVERSEAS BRANCH, 1ST, FLOOR, EARNEST HOUSE, NARIMAN POINT, MAHARASHTRA - 400021, INDIA

A71369730

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2015

(Rs. in Million)

31.03.2014

(Rs. in Million)

LONG TERM BORROWINGS

 

 

Loan from Department of Science and Technology

68.199

81.839

SHORT TERM BORROWINGS

 

 

Working capital demand loan

0.000

85.000

Total

68.199

166.839

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Office building
  • Plant and equipment
  • Factory equipments
  • Furniture and fixtures
  • Vehicles
  • Motor vehicles
  • Office equipment

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.22

UK Pound

1

Rs.99.93

Euro

1

Rs.71.67

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

KYP

 

 

Report Prepared by :

PNM


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

51

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.